Clinical observation on the treatment of patients with chronic hepatitis B with interferon α-2b,interferon α-2b and interferon α-1b
Yingjie Liang
Abstract
Yingjie Liang
Abstract
Objective To observe different interferon-α in the treatment of patients with chronic hepatitis B.Methods 180 patients with chronic hepatitis B were randomly divided into group A,B and C(60 patients in each group).The patients in group A was treated with interferon α2b,in group B was treated with interferon α2b and in group C was treated with interferon α1b for 12 months.Results At the end of the treatment,the ALT normalization rates in group A,B and C were 68.3%,68.3% and 65.0%;the negative rate of HBeAg were 70.0%,71.7% and 66.7%;the negative rate of HBV DNA were 73.3%,73.3% and 70.0%;the hualuronic acid,procollagen Ⅲ,Ⅳ-collager and laminin in the three groups were not significantly different;However,common side effects in group B were most obvious than in group A and C.Conclusion The efficacy of domestic interferon-α in treatment of patients with chronic hepatitis B is the same.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To observe different interferon-α in the treatment of patients with chronic hepatitis B.Methods 180 patients with chronic hepatitis B were randomly divided into group A,B and C(60 patients in each group).The patients in group A was treated with interferon α2b,in group B was treated with interferon α2b and in group C was treated with interferon α1b for 12 months.Results At the end of the treatment,the ALT normalization rates in group A,B and C were 68.3%,68.3% and 65.0%;the negative rate of HBeAg were 70.0%,71.7% and 66.7%;the negative rate of HBV DNA were 73.3%,73.3% and 70.0%;the hualuronic acid,procollagen Ⅲ,Ⅳ-collager and laminin in the three groups were not significantly different;However,common side effects in group B were most obvious than in group A and C.Conclusion The efficacy of domestic interferon-α in treatment of patients with chronic hepatitis B is the same.
Key concepts: Medicine, Interferon, Chronic hepatitis, HBeAg, Gastroenterology, Internal medicine, Group A, Group B